Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [843]

Part 8: How PARP inhibitors are being used now

Prof Philip Cornford - Royal Liverpool University Hospital, Liverpool, UK

Part 8: How PARP inhibitors are being used now ( Prof Philip Cornford - Royal Liverpool University Hospital, Liverpool, UK )

Part 9: What PARP inhibitors mean for the future and what to look out for

Prof Philip Cornford - Royal Liverpool University Hospital, Liverpool, UK

Part 9: What PARP inhibitors mean for the future and what to look out for ( Prof Philip Cornford - Royal Liverpool University Hospital, Liverpool, UK )

Update from ASCO Breakthrough Asia Conference 2023

Dr Roselle de Guzman - Manila Central University-FDTMF Hospital, Manila...

Update from ASCO Breakthrough Asia Conference 2023 ( Dr Roselle de Guzman - Manila Central University-FDTMF Hospital, Manila, Philippines )

The impact of SEABCS 2023

Dr Heather White - Executive Director, TogetHER for Health

The impact of SEABCS 2023 ( Dr Heather White - Executive Director, TogetHER for Health )

OncoAlert Round Up for August 18th - 24th, 2023

Dr Gil Morgan - Executive Director, OncoAlert

OncoAlert Round Up for August 18th - 24th, 2023 ( Dr Gil Morgan - Executive Director, OncoAlert )

AOH1996 treatment targeting PCNA shows promise for reoccurring solid tumours

Dr Linda Malkas - City of Hope, Duarte, USA

AOH1996 treatment targeting PCNA shows promise for reoccurring solid tumours ( Dr Linda Malkas - City of Hope, Duarte, USA )

Potential benefit to response rates from trastuzumab added to perioperative...

Dr Anna Wagner - The University of Lausanne, Lausanne, Switzerland, Co-chair of...

Potential benefit to response rates from trastuzumab added to perioperative chemotherapy for patients with HER-2+ GC ( Dr Anna Wagner - The University of Lausanne, Lausanne, Switzerland, Co-chair of the EORTC Gastric Cancer Task Force )

Lenvatinib plus pembrolizumab versus standard of care for previously treated...

Dr Akihito Kawazoe - National Cancer Center Hospital East, Kashiwa, Japan

Lenvatinib plus pembrolizumab versus standard of care for previously treated metastatic colorectal cancer ( Dr Akihito Kawazoe - National Cancer Center Hospital East, Kashiwa, Japan )

Whole exome sequencing reveals genomic landscape of appendiceal adenocarcinoma

Dr Michael White - MD Anderson Cancer Center, Houston, USA

Whole exome sequencing reveals genomic landscape of appendiceal adenocarcinoma ( Dr Michael White - MD Anderson Cancer Center, Houston, USA )

Selinexor, bortezomib and dexamethasone shows PFS benefit for multiple myeloma

Dr Maria-Victoria Mateos - University Hospital Salamanca, Salamanca, Spain

Selinexor, bortezomib and dexamethasone shows PFS benefit for multiple myeloma ( Dr Maria-Victoria Mateos - University Hospital Salamanca, Salamanca, Spain )

ADCLEC.syn1 and CD33-CARS in humanised acute myeloid leukaemia models shows...

Dr Sascha Haubner - Memorial Sloan Kettering Cancer Center, New York City, USA

ADCLEC.syn1 and CD33-CARS in humanised acute myeloid leukaemia models shows promising efficacy ( Dr Sascha Haubner - Memorial Sloan Kettering Cancer Center, New York City, USA )

Ide-cel significantly prolongs PFS for r/r multiple myeloma versus standard...

Dr Krina Patel - MD Anderson Cancer Center, Houston, USA

Ide-cel significantly prolongs PFS for r/r multiple myeloma versus standard regimens ( Dr Krina Patel - MD Anderson Cancer Center, Houston, USA )

More from ecancer